SQM up +4.37% percent Today $SQM High is at 26.79 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 19, 2014 at 11:20 AM

SQM up +4.37% percent Today $SQM High is at 26.79 and the Low 25.60 with current volume of 159,403.

Recent News posted below.

Sociedad Quimica Y Minera S.A. SQM other info.
http://investorshangout.com/Sociedad-Quimica-...SQM-52700/

SQM Sociedad Quimica Y Minera S.A. Recent Headline News

Sociedad Quimica y Minera de Chile misses by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 2:04AM CST

SQM: 26.20 (+1.05)

SQM Reports Earnings For The Third Quarter 2014
PR Newswire - Tue Nov 18, 5:29PM CST
Sociedad Quimica y Minera de Chile S.A. (SQM) (NYSE: SQM; Santiago Stock Exchange: SQM-B, SQM-A) reported today earnings for the nine months ended September 30, 2014 of US$218.4 million (US$0.83 per ADR), a decrease from US$398.1 million (US$1.51 per ADR) for the nine months ended September 30, 2013. Gross margin reached US$442.6 million (29.1% of revenues) for the nine months ended September 30, 2014, lower than US$575.2 million (33.6% of revenues) recorded for the nine months ended September 30, 2013. Revenues totaled US$1,522.8 million for the nine months ended September 30, 2014, representing a decrease of 11.0% compared to US$1,710.9 million reported for the nine months ended September 30, 2013.
SQM: 26.20 (+1.05)

Sociedad Quimica y Minera de Chile Shares Down 10.4% Since SmarTrend's Sell Call (SQM)
Comtex SmarTrend(R) - Tue Nov 18, 5:02PM CST
SmarTrend identified a Downtrend for Sociedad Quimica y Minera de Chile (NYSE:SQM) on May 15th, 2014 at $28.08. In approximately 6 months, Sociedad Quimica y Minera de Chile has returned 10.43% as of today's recent price of $25.15.
SQM: 26.20 (+1.05)

16.5% Return Seen to Date on SmarTrend Sociedad Quimica y Minera de Chile Call (SQM)
Comtex SmarTrend(R) - Tue Nov 11, 11:06AM CST
SmarTrend identified a Downtrend for Sociedad Quimica y Minera de Chile (NYSE:SQM) on May 15th, 2014 at $28.08. In approximately 6 months, Sociedad Quimica y Minera de Chile has returned 16.52% as of today's recent price of $23.44.
SQM: 26.20 (+1.05)

SQM Filed Its Annual Report On Form 20-F For The Year 2013 On April 29, 2014
PR Newswire - Thu Oct 30, 4:34PM CDT
Sociedad Quimica y Minera de Chile S.A. (SQM) (NYSE: SQM; Santiago Stock Exchange: SQM-A, SQM- announced today that it filed its Annual Report on Form 20-F for the year 2013 with the U.S. Securities and Exchange Commission on April 29, 2014. The Form 20-F is available on the Company's website (www.sqm.com).
SQM: 26.20 (+1.05)

Shares of SQM Down 18.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Oct 28, 9:17AM CDT
SmarTrend identified a Downtrend for Sociedad Quimica y Minera de Chile (NYSE:SQM) on May 15th, 2014 at $28.08. In approximately 6 months, Sociedad Quimica y Minera de Chile has returned 18.34% as of today's recent price of $22.93.
SQM: 26.20 (+1.05)

SQM announces pricing of Notes due 2025
PR Newswire - Thu Oct 23, 5:41PM CDT
Sociedad Quimica y Minera de Chile S.A. (SQM) (NYSE: SQM; Santiago Stock Exchange: SQM-A, SQM- reported that it has priced today a US$250 million aggregate principal amount of 4.375% Notes due 2025 (equivalent to a spread of 215 basis points over the US treasury). The notes were offered to investors at a price of 99.410% of principal amount.
SQM: 26.20 (+1.05)

Orocobre Provides Exposure To Lithium M&A Activity
Livio Filice - at Seeking Alpha - Wed Oct 22, 4:58PM CDT

SQM: 26.20 (+1.05), ROC: 78.77 (-0.21), ALB: 61.25 (-0.44), FMC: 56.29 (-0.50), TM: 119.56 (-0.51)

Sociedad Quimica y Minera de Chile Has Returned 17.9% Since SmarTrend Recommendation (SQM)
Comtex SmarTrend(R) - Mon Oct 20, 5:05PM CDT
SmarTrend identified a Downtrend for Sociedad Quimica y Minera de Chile (NYSE:SQM) on May 15th, 2014 at $28.08. In approximately 5 months, Sociedad Quimica y Minera de Chile has returned 17.91% as of today's recent price of $23.05.
SQM: 26.20 (+1.05)

Sociedad Quimica y Minera de Chile (SQM): Moving Average Crossover Alert - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 8:37AM CDT
Sociedad Quimica y Minera de Chile (SQM): Moving Average Crossover Alert
SQM: 26.20 (+1.05)

Sociedad Quimica y Minera de Chile Earnings In Retrospect: Down 2.9% in the Last 20 Days (SQM)
Comtex SmarTrend(R) - Mon Sep 15, 6:56AM CDT
Two weeks ago on August 26th, 2014 Sociedad Quimica y Minera de Chile (NYSE:SQM) reported earnings and analysts, on average, expected earnings of $0.31 on sales of $520.6 million. The company actually reported a break-even quarter on sales of $522.3 million, missing EPS estimates by $0.31 and beating revenue estimates by $1.7 million. Shares of Sociedad Quimica y Minera de Chile have slipped from $28.14 to $27.33, representing a loss of 2.9%, since the company reported earnings 20 days ago.
SQM: 26.20 (+1.05)

Post Earnings Update: Sociedad Quimica y Minera de Chile Has Sunk 0.8% Lower in Past Week (SQM)
Comtex SmarTrend(R) - Mon Sep 08, 7:03AM CDT
13 days ago, on August 26th, 2014, Sociedad Quimica y Minera de Chile (NYSE:SQM) reported its earnings. Analysts, on average, expected earnings of $0.31 per share on sales of $520.6 million. The company actually reported a break-even quarter on sales of $522.3 million, missing EPS estimates by $0.31 and beating revenue estimates by $1.7 million. Since the company's report, shares of Sociedad Quimica y Minera de Chile have fallen from $28.14 to $27.91, representing a loss of 0.8% in the past 13 days.
SQM: 26.20 (+1.05)

What To Hold: 3 Hold-Rated Dividend Stocks LINE, LPT, SQM
at The Street - Tue Sep 02, 10:30AM CDT
These 3 dividend stocks are rated a Hold by TheStreet
SQM: 26.20 (+1.05), LPT: 35.18 (-0.18), LINE: 22.76 (-0.19)

SQM posts lower net income of USD71.1m for Q2 2014
M2 - Wed Aug 27, 3:05AM CDT
Plant nutrients company Sociedad Quimica y Minera de Chile S.A. (NYSE:SQM)(Santiago Stock Exchange:SQM- (Santiago Stock Exchange:SQM-A) Tuesday announced its net income of USD71.1m (USD0.27 per ADR) for the Q2 2014.
SQM: 26.20 (+1.05)

SQM Reports Earnings For The Second Quarter 2014
PR Newswire Europe - Tue Aug 26, 7:37PM CDT
Sociedad Quimica y Minera de Chile S.A. (SQM) reported today earnings for the six months ended June 30, 2014 of US$152.1 million (US$0.58 per ADR), a decrease from US$259.2 million (US$0.98 per ADR) for the six months ended June 30, 2013. Gross Margin(2 )reached US$300.2 million (28.4% of revenues) for the six months ended June 30, 2014, lower than US$426.7 million (35.9% of revenues) recorded for the six months ended June 30, 2013. Revenues totaled US$1,056.4 million for the six months ended June 30, 2014, representing a decrease of 11.2% compared to US$1,189.9 million reported for the six months ended June 30, 2013.
SQM: 26.20 (+1.05)

CF Industries (CF) Remains on Track with Expansion Projects - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 12:20PM CDT
We have issued an updated research report on fertilizer maker CF Industries (CF).
SQM: 26.20 (+1.05), CE: 60.48 (-0.40), CF: 272.56 (+2.87)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Clarins Dazzles Austin with Skin Longevity Event

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...